These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35358943)

  • 41. Corporate political activity of the dairy industry in France: an analysis of publicly available information.
    Mialon M; Mialon J
    Public Health Nutr; 2017 Sep; 20(13):2432-2439. PubMed ID: 28689497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring health researchers' perceptions of policymaking in Argentina: a qualitative study.
    Corluka A; Hyder AA; Winch PJ; Segura E
    Health Policy Plan; 2014 Sep; 29 Suppl 2(Suppl 2):ii40-9. PubMed ID: 25274639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public opinion of alcohol industry corporate political activities.
    Miller P; Martino F; Robertson N; Stafford J; Daube M
    Aust N Z J Public Health; 2021 Jun; 45(3):283-289. PubMed ID: 34028934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.
    Mialon M; Vandevijvere S; Carriedo-Lutzenkirchen A; Bero L; Gomes F; Petticrew M; McKee M; Stuckler D; Sacks G
    BMJ Open; 2020 Jul; 10(7):e034082. PubMed ID: 32690498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-regulation and alcohol industry political strategy: A case study of the Public Health England-Drinkaware Drink Free Days Campaign.
    Hawkins B; Durrance-Bagale A; Walls H
    Soc Sci Med; 2021 Sep; 285():114175. PubMed ID: 34388623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The devil is in the detail: tobacco industry political influence in the Dutch implementation of the 2001 EU Tobacco Products Directive.
    Lie JL; Willemsen MC; de Vries NK; Fooks G
    Tob Control; 2016 Sep; 25(5):545-50. PubMed ID: 26349910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Political and institutional influences on the use of evidence in public health policy. A systematic review.
    Liverani M; Hawkins B; Parkhurst JO
    PLoS One; 2013; 8(10):e77404. PubMed ID: 24204823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond policy analysis: the raw politics behind opposition to healthy public policy.
    Raphael D
    Health Promot Int; 2015 Jun; 30(2):380-96. PubMed ID: 24870808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health policy--why research it and how: health political science.
    de Leeuw E; Clavier C; Breton E
    Health Res Policy Syst; 2014 Sep; 12():55. PubMed ID: 25248956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A framework of NGO inside and outside strategies in the commercial determinants of health: findings from a narrative review.
    Townsend B; Johnson TD; Ralston R; Cullerton K; Martin J; Collin J; Baum F; Arnanz L; Holmes R; Friel S
    Global Health; 2023 Oct; 19(1):74. PubMed ID: 37817196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of theories of the policy process in research on consumption of sustainable diets: a systematic review.
    Green C; Carey G; Joyce A
    BMC Public Health; 2022 Jul; 22(1):1335. PubMed ID: 35831842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Private and personal": Corporate political activity, informal governance, and the undermining of marketing regulation in Brazil.
    Carvalho CMP; Johns P; Albiero M; Martins APB; Mais LA; Ralston R; Collin J
    Glob Public Health; 2022; 17(9):1902-1912. PubMed ID: 34648410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commercial lobbying and political contributions: an Australian scoping review.
    Lacy-Nichols J; Johnson M; Cullerton K
    Aust N Z J Public Health; 2023 Aug; 47(4):100073. PubMed ID: 37478519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding the Political Organization and Tactics of the Alcohol Industry in Ireland 2009-2018.
    Lesch M; McCambridge J
    J Stud Alcohol Drugs; 2022 Jul; 83(4):574-581. PubMed ID: 35838435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From millstones to milestones: Scaffolding a house of public health on political science foundations.
    Shroff FM; Prakash S; Varao-Sousa TL
    Educ Health (Abingdon); 2021; 34(3):101-104. PubMed ID: 35488656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corporations' use and misuse of evidence to influence health policy: a case study of sugar-sweetened beverage taxation.
    Fooks GJ; Williams S; Box G; Sacks G
    Global Health; 2019 Sep; 15(1):56. PubMed ID: 31551086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing.
    McCambridge J; Hawkins B; Holden C
    Addiction; 2014 Feb; 109(2):199-205. PubMed ID: 24261642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How are frames generated? Insights from the industry lobby against the sugar tax in Ireland.
    Campbell N; Mialon M; Reilly K; Browne S; Finucane FM
    Soc Sci Med; 2020 Nov; 264():113215. PubMed ID: 32889504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Methodological aspects of the reconstitution and evaluation of the behavioral theories that underlie population policy].
    Leeuw F
    Politiq Popul; 1991 Sep; 4(4):5-42. PubMed ID: 12285025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Who is donating to political parties in Queensland, Australia? An analysis of political donations from the food industry.
    Russell C; Hussain NAB; Sievert K; Cullerton K
    Public Health Nutr; 2023 Jul; 26(7):1501-1512. PubMed ID: 36855788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.